Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as Screening Instruments for Depression in Stroke Patients

2002 ◽  
Vol 43 (5) ◽  
pp. 386-393 ◽  
Author(s):  
Ivo Aben ◽  
Frans Verhey ◽  
Richel Lousberg ◽  
Jan Lodder ◽  
Adriaan Honig
2012 ◽  
Vol 73 (2) ◽  
pp. 139-144 ◽  
Author(s):  
Valjbona T. Preljevic ◽  
Tone Brit Hortemo Østhus ◽  
Leiv Sandvik ◽  
Stein Opjordsmoen ◽  
Inger Hilde Nordhus ◽  
...  

2011 ◽  
Vol 26 (S2) ◽  
pp. 599-599
Author(s):  
Z. Al-Salihy ◽  
T. Rahim ◽  
A. Mitchell ◽  
M. Mahmud ◽  
A. Muhyaldin

IntroductionUstun et al estimated that depression is the fourth leading cause of global disease burden. The burden of depression on the healthcare system is equally significant with an estimated US annual cost of approximately $26 billion (1990). In a European epidemiologic study of mental disorders involving six countries, major depression was the single most common disorder assessed, with a 12-month prevalence of 3.9%.ObjectivesOur aim was to find the optimal tool with the highest accuracy in comparison to the (MINI) for depression.AimsWe aimed to find the depression rating scale with the highest accuracy when applied by psychiatrists in Iraq.MethodsWe recruited 400 subjects; The (MINI) was used as a gold standard to define the presence of major depression according to DSMIV criteria stratified into 200 patients with primary depression and 200 non-depressed subjects in Kurdistan region of Iraq. We examined the symptoms of depression using the Hospital Anxiety and Depression Scale (HADS) and Clinical Global Impression (CGI). Interviews were performed by three psychiatrists who were blinded to the group allocations. ROC curve analysis was used.ResultsBoth HADS and CGI performed with high accuracy compared with the MINI interview for DSMIV major depression. Clinicians using the CGI were accurate in their clinical judgement with sensitivity of 97% and specificity of 99%.ConclusionsWe found the psychiatrist's opinion alone was very accurate with higher sensitivity and specificity than the HADS and therefore it is unclear from our sample if questionnaires would help clinicians in their diagnoses.


2021 ◽  
Vol 11 (60) ◽  
pp. 4686-4695
Author(s):  
Maira Gabriela Paetzold ◽  
Ligiane De Lourdes Silva ◽  
Márcia Regina Simões

Objetivo: A presente pesquisa teve como objetivo realizar uma revisão integrativa da literatura de instrumentos utilizados no rastreamento de depressão, ansiedade e misto (ambos) em amostras de estudantes de graduação. Método: a pesquisa ocorreu na base de dados PubMed, de 2009 até 2019. Resultados: Inicialmente foram encontrados 895 artigos, dos quais 345 foram incluídos após a leitura dos títulos e resumos; destes, 316 foram recuperados e posteriormente 176 foram excluídos após a leitura na íntegra, totalizando 140 artigos. Conclusão: Os instrumentos mais utilizados foram: a) Ansiedade: Beck Anxiety Inventory (BAI) (n=19) e State-Trait Anxiety Inventory (STAI) (n=17); b) Depressão: Beck Depression Inventory (BDI) (n=35); e c) Misto: Depression, Anxiety and Stress Scale (DASS-21) (n=40) e Hospital Anxiety and Depression Scale (HADS) (n=19). O curso mais avaliado foi Medicina e os países com mais produções de artigos foram China (n=24) e Estados Unidos (n=20). O Brasil publicou apenas 7 artigos.


2019 ◽  
Vol 27 (4) ◽  
pp. 381-390 ◽  
Author(s):  
Mechthild Westhoff-Bleck ◽  
Lotta Winter ◽  
Lukas Aguirre Davila ◽  
Christoph Herrmann-Lingen ◽  
Jens Treptau ◽  
...  

Objective The purpose of this study was the diagnostic evaluation of the hospital anxiety and depression scale total score, its depression subscale and the Beck depression inventory II in adults with congenital heart disease. Methods This cross-sectional study evaluated 206 patients with congenital heart disease (mean age 35.3 ± 11.7 years; 58.3% men). Major depressive disorder was diagnosed by a structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders IV and disease severity with the Montgomery–Åsberg depression rating scale. Receiver operating characteristics provided assessment of diagnostic accuracy. Youden’s J statistic identified optimal cut-off points. Results Fifty-three participants (25.7%) presented with major depressive disorder. Of these, 28 (52.8%) had mild and 25 (47.2%) had moderate to severe symptoms. In the total cohort, the optimal cut-off of values was >11 in the Beck depression inventory II, >11 in the hospital anxiety and depression scale and >5 in the depression subscale. Optimal cut-off points for moderate to severe major depressive disorder were similar. The cut-offs for mild major depressive disorder were lower (Beck depression inventory II >4; hospital anxiety and depression scale >8; >2 in its depression subscale). In the total cohort the calculated area under the curve varied between 0.906 (hospital anxiety and depression scale) and 0.93 (Beck depression inventory II). Detection of moderate to severe major depressive disorder (area under the curve 0.965–0.98) was excellent; detection of mild major depressive disorder (area under the curve 0.851–0.885) was limited. Patients with major depressive disorder had a significantly lower quality of life, even when they had mild symptoms. Conclusion All scales were excellent for detecting moderate to severe major depressive disorder. Classification of mild major depressive disorder, representing 50% of cases, was limited. Therapy necessitating loss of quality of life is already present in major depressive disorder with mild symptoms. Established cut-off points may still be too high to identify patients with major depressive disorder requiring therapy. External validation is needed to confirm our data.


2017 ◽  
Vol 41 (S1) ◽  
pp. S236-S236 ◽  
Author(s):  
H. Hoang ◽  
E. Stenager ◽  
E. Stenager

ObjectiveTo examine the risk of depression and anxiety in MS patients in the post-diagnostic period by using clinical screening instruments and a diagnostic structured clinical interview.MethodA population of 134 MS patients was examined for the risk of depression and anxiety in the post-diagnostic period of MS using the clinical screening instruments Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS). Within six weeks of diagnosis, patients with cut-off > 12 for BDI and > 7 for HADS were offered a clinical structured interview using the Schedules for Clinical Assessment in Neuropsychiatry/SCAN Version 2.1.ResultsThe prevalence of depressive symptoms and depression in the post-diagnostic period of MS was 49.2% when using the screening instruments, but only 15.2% when using the SCAN interview. For anxiety, the prevalence was 3.4% for both the screening instruments and the SCAN interview in the post-diagnostic period of MS.ConclusionMS patients have a risk of depression and anxiety in the post-diagnostic period of MS, but it is crucial to consider which tools to use in a clinical setting to investigate depression and anxiety in MS patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document